Intravenous Erythropoietin (rHuEPO) Administration Increases Plasma Endothelin and Blood Pressure in Hemodialysis Patients

American Journal of Hypertension

Volumn 6, Issue 2, 1993, Pages 103-107

  Rothstein, Marcos ^a   Carlini, Raul ^a   Obialo, Chamberlain I ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Hemodialysis; Hypertension; Plasma endothelin; Recombinant human erythropoietin

Indexed keywords

ENDOTHELIN; NANDROLONE DECANOATE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; AGING; ANEMIA; BLOOD PRESSURE; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELINS; ERYTHROPOIETIN; FEMALE; HEMATOCRIT; HUMAN; HYPERTENSION; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGE; RECOMBINANT PROTEINS; RENAL DIALYSIS;

EID: 0027468805     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/6.2.103     Document Type: Article

References (23)

1. Eschbach JW, Abdulhadi MH, Browne JK,: Recombinant human erythropoietin in anemic patients with end stage renal disease: Results of a phase III multicenter clinical trial. Ann Intern Med 1989; 111: 992-1000.
2. Sundal E, Kaeser U: Correction of anemia of chronic renal failure with recombinant human erythropoietin. Safety and efficacy of one year's treatment in a European multicenter study of 150 hemodialysis-dependent patients. Nephrol Dial Transplant 1989; 4: 979-987.
3. Steffen HM, Brunner R, Muller R,: Peripheral hemodynamics, blood viscosity and the renin-angiotensin system in hemodialysis patients under therapy with recombinant human erythropoietin. Contrib Nephrol 1989; 76: 292-298.
4. Duke M, Abelman W: The hemodynamic response to chronic anemia. Circulation 1969; 39: 503-515.
5. Heidenreich S, Rahn KH, Zidek W: Erythropoietin induces contraction of isolated renal small resistance vessels. Nephrol Dial Transplant 1990; 5: 739-740.
6. Jamgotchian N, Krall JF, Hu MS,: An animal model for recombinant human erythropoietin (rHuEPO)-induced hypertension (abst). Kidney Int 1990; 37: 387.
7. Yanagisawa M, Kurihara H, Kimura S,: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
8. Kohno M, Yasunari K, Murakawa K,: Plasma immunoreaction endothelin in essential hypertension. Am J Med 1990; 88: 614-618.
9. Warrens AN, Cassidy MJD, Takahashi K,: Endothelin in renal failure. Nephrol Dial Transplant 1990; 5: 418-422.
10. Rodeheffer RJ, Lerman A, Heublein DM,: Increased plasma concentration of endothelin in congestive heart failure in humans. Mayo Clin Proc 1992; 67: 719-724.
11. Mortensen LH, Pawloski CM, Kanagy NL,: Chronic hypertension produced by infusion of endothelin in rats. Hypertension 1990; 15: 729-733.
12. Anagnostou A, Lee ES, Kessimian N,: Erythropoietin has mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci 1990; 87: 5978-5982.
13. Yamashita W, Kamizono A, Ohasi T,: Recombinant human erythropoietin (rHuEPO) induces high plasma endothelin (ET) levels in hemodialysis patients (abst). J Am Soc Nephrol 1990, 1: 409.
14. Nonnast-Daniel B, Frei U, Pollok M,: Correction of renal anemia by daily subcutaneous administration of erythropoietin: An approach to avoid the induction of hypertension (abst). Nephrol Dial Transplant 1990; 5: 742.
15. Lim VS, Flanigan MJ: Blood pressure (BP) and r-HuEPO therapy (abst). J Am Soc Nephrol 1991; 2: 3; 381.
16. Koyama H, Nishzawa Y, Morii H,: Plasma endothelin levels in patients with uremia. Lancet 1989; 1: 991-992.
17. Raine AEG, Roger SD: Effect of erythropoietin on blood pressure. Am J Kid Dis 1991; 18(suppl): 76-83.
18. Hori K, Onoyama K, Iseki K,: Hemodynamics and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients. Clin Nephrol 1990; 33: 293-298.
19. Nonnast-Daniel B, Frei U, Brabant EG,: Atrial natriuretic peptide and central hemodynamics during correction of renal anemia by recombinant human erythropoietin treatment in regular dialysis treatment patients (abst). Nephrol Dial Transplant 1989; 4: 478.
20. Samtleben W, Baldamus CA, Bommer J,: Blood pressure change during treatment with recombinant human erythropoietin. Contrib Nephrol 1988; 66: 114-122.
21. Yoshizumi M, Kurihara H, Morita T,: Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun 1990; 166: 324-329.
22. Bunchman TE, Brookshire CA: Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 1991; 88: 310-314.
23. Mc Mahon FG, Vargas R, Ryan M,: Pharmacokinetics and effect of recombinant erythropoietin after intravenous and subcutaneous injection in healthy volunteers. Blood 1990; 76: 1718-1722.